Eye-Docs Limited iXBRL

Company Registration Number: 04414314

Eye-Docs Limited

Annual Report and Financial Statements

for the financial year ended 31 December 2024

Eye-Docs Limited

DIRECTORS AND OTHER INFORMATION


Directors	S Shah
	J Moore
	R Sivaraj


Company Registration Number	04414314


Registered Office	50 Lode Lane
	Solihull
	West Midlands
	B91 2AW
	England and Wales


Business Address	50 Lode Lane
	Solihull
	West Midlands
	B91 2AW


Independent Auditors	Muldoon & Co
	16 Mount Charles
	Belfast
	BT7 1NZ
	Northern Ireland


Bankers	Bank of Scotland
	The Mound
	EH1 1YZ
	Scotland


	Metro Bank
	Metro Bank PLC
	One Southampton Row
	London
	WC1B 5HA
	England


	Cater Allen Private Bank
	Santander House
	9 Nelson Street
	Bradford
	BD1 5AN
	England

Eye-Docs Limited

DIRECTORS' REPORT

for the financial year ended 31 December 2024

The directors present their report and the audited financial statements for the financial year ended 31 December 2024.

Directors

The directors who served during the financial year are as follows:

S Shah

J Moore

R Sivaraj

There were no changes in shareholdings between 31 December 2024 and the date of signing the financial statements.

Statement of Directors' Responsibilities

The directors are responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” Section 1A (Small Entities). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and apply them consistently;

-make judgements and accounting estimates that are reasonable and prudent;

-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Disclosure of Information to Auditor
Each persons who are directors at the date of approval of this report confirms that:
In so far as the directors are aware:
-there is no relevant audit information (information needed by the company's auditor in connection with preparing the auditor's report) of which the company's auditor is unaware, and
-the directors have taken all the steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information.

Auditors

The auditors, Muldoon & Co have indicated their willingness to continue in office in accordance with the provisions of Section 485 of the Companies Act 2006.

Special provisions relating to small companies

The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.

On behalf of the board

___________________________

S Shah

Director

___________________________

J Moore

Director

___________________________

R Sivaraj

Director

3 July 2025

INDEPENDENT AUDITOR'S REPORT

to the Shareholders of Eye-Docs Limited

Report on the audit of the financial statements

Opinion

We have audited the financial statements of Eye-Docs Limited ('the company') for the financial year ended 31 December 2024 which comprise the Statement of Financial Position and the related notes to the financial statements, including significant accounting policies set out in note . The financial reporting framework that has been applied in their preparation is applicable Law and United Kingdom Accounting Standards, including FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” Section 1A (Small Entities).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its profit for the financial year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from the date when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other Information

The other information comprises the information included in the annual report other than the financial statements and our Auditor's Report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinion on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Directors' Report has been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified any material misstatements in the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept; or

the financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors' remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit; or

the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption in preparing the Directors' Report.

Responsibilities of directors for the financial statements

The directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or has no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditor's Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

- Enquire of management, those charged with governance and the entity's solicitors around the actual and potential
litigation and claims;

- Enquiry of entity staff in tax and compliance functions to identify any instances of non - compliance with laws and
regulations;

- Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with
applicable laws and regulations;

- Performing audit work over the risk of management override of controls, including testing of journal entries and
other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the
normal course of business and reviewing accounting estimates.

A further description of our responsibilities for the audit of the financial statements is contained in the appendix to this report, located at page , which is to be read as an integral part of our report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

__________________________________

Robert Barr (Senior Statutory Auditor)

for and on behalf of

MULDOON & CO

16 Mount Charles

Belfast

BT7 1NZ

Northern Ireland

3 July 2025

Eye-Docs Limited

APPENDIX TO THE INDEPENDENT AUDITOR'S REPORT

Further information regarding the scope of our responsibilities as auditor

As part of an audit in accordance with ISAs (UK), we exercise professional judgement and maintain professional scepticism throughout the audit. We also:

Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company's internal control.

Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the directors.

Conclude on the appropriateness of the directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our Auditor's Report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our Auditor's Report. However, future events or conditions may cause the company to cease to continue as a going concern.

Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

Eye-Docs Limited

Company Registration Number: 04414314

STATEMENT OF FINANCIAL POSITION

as at 31 December 2024

		2024	2023
	Notes	£	£

Fixed Assets

Tangible assets

328,450

317,433

─────────

Current Assets

Stocks

139,546

136,045

Debtors

2,132,183

1,812,107

Cash and cash equivalents

1,940,071

1,332,459

─────────

4,211,800

3,280,611

─────────

Creditors: amounts falling due within one year

(1,891,722)

(1,721,771)

─────────

Net Current Assets

2,320,078

1,558,840

─────────

Total Assets less Current Liabilities

2,648,528

1,876,273

Provisions for liabilities

11,050

─────────

Net Assets

2,659,578

1,876,276

═════════

Capital and Reserves

Called up share capital

Retained earnings

2,659,498

1,876,196

─────────

Equity attributable to owners of the company

2,659,578

1,876,276

═════════

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).

The company has taken advantage of the exemption under section 444 not to file the Income Statement.

Approved by the Board and authorised for issue on 3 July 2025 and signed on its behalf by

________________________________

S Shah

Director

________________________________

J Moore

Director



________________________________
R Sivaraj
Director

Eye-Docs Limited

NOTES TO THE FINANCIAL STATEMENTS

for the financial year ended 31 December 2024

General Information

Eye-Docs Limited is a company limited by shares incorporated and registered in the England and Wales. The registered number of the company is 04414314. The registered office of the company is 50 Lode Lane, Solihull, West Midlands, B91 2AW, England and Wales. The principal activity of the Company is that of specialist medical practice activities. The financial statements have been presented in Pound (£) which is also the functional currency of the company.

Summary of Significant Accounting Policies

The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.

Statement of compliance

The financial statements of the company for the financial year ended 31 December 2024 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.

Turnover

Turnover comprises the invoice value of goods supplied by the company, exclusive of discounts.

Judgements and key sources of estimation uncertainty

In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revisiion affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Tangible assets and depreciation

Tangible assets are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of tangible assets, less their estimated residual value, over their expected useful lives as follows:

Long leasehold property

20% Straight line

Plant and machinery

20% Straight line

The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.

Leasing and hire purchases

Tangible assets held under leasing and Hire Purchases arrangements which transfer substantially all the risks and rewards of ownership to the company are capitalised and included in the Statement of Financial Position at their cost or valuation, less depreciation. The corresponding commitments are recorded as liabilities. Payments in respect of these obligations are treated as consisting of capital and interest elements, with interest charged to the Income Statement.

Stocks

Stocks are valued at the lower of cost and net realisable value. Stocks are determined on a first-in first-out basis. Cost comprises expenditure incurred in the normal course of business in bringing stocks to their present location and condition. Full provision is made for obsolete and slow moving items. Net realisable value comprises actual or estimated selling price (net of trade discounts) less all further costs to completion or to be incurred in marketing and selling.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Borrowing costs

Borrowing costs relating to the acquisition of assets are capitalised at the appropriate rate by adding them to the cost of assets being acquired. Investment income earned on the temporary investment of specific borrowings pending their expenditure on the assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.

Provisions

Provisions are recognised when the company has a present legal or constructive obligation arising as a result of a past event, it is probable that an outflow of economic benefits will be required to settle the obligation and a reliable estimate can be made. Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a pre-tax rate that reflects current market assessments of the same value of money and the risks specific to the obligation. The increase in the provision due to passage of time is recognised as interest expense.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recoginsed as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the emploee's services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Taxation and deferred taxation

Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Statement of Financial Position date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Statement of Financial Position date.

Ordinary share capital

The ordinary share capital of the company is presented as equity.

Employees

The average monthly number of employees, including directors, during the financial year was:

2024

2023

Number

Number

Employees

═════════


4.	Tangible assets
		Long	Plant and	Total
		leasehold	machinery
		property
		£	£	£
	Cost
	At 1 January 2024	776,321	1,488,776	2,265,097
	Additions	64,088	43,428	107,516
		─────────	─────────	─────────
	At 31 December 2024	840,409	1,532,204	2,372,613
		─────────	─────────	─────────
	Depreciation
	At 1 January 2024	584,950	1,362,714	1,947,664
	Charge for the financial year	30,986	65,513	96,499
		─────────	─────────	─────────
	At 31 December 2024	615,936	1,428,227	2,044,163
		─────────	─────────	─────────
	Net book value
	At 31 December 2024	224,473	103,977	328,450
		═════════	═════════	═════════
	At 31 December 2023	191,371	126,062	317,433
		═════════	═════════	═════════


5.	Stocks	2024	2023
		£	£

	Finished goods and goods for resale	139,546	136,045
		═════════	═════════


6.	Debtors	2024	2023
		£	£

	Trade debtors	556,355	530,338
	Amounts owed by group undertakings	1,279,591	1,039,591
	Other debtors	39,444	36,689
	Prepayments and accrued income	256,793	205,489
		─────────	─────────
		2,132,183	1,812,107
		═════════	═════════


7.	Creditors	2024	2023
	Amounts falling due within one year	£	£

	Bank overdrafts	-	4,206
	Trade creditors	434,362	344,483
	Amounts owed to group undertakings	672,500	672,500
	Taxation (Note 8)	195,695	133,094
	Other creditors	11,043	40,436
	Accruals	578,122	527,052
		─────────	─────────
		1,891,722	1,721,771
		═════════	═════════


8.	Taxation	2024	2023
		£	£

	Creditors:
	Corporation tax	139,493	96,740
	PAYE / NI	56,202	36,354
		─────────	─────────
		195,695	133,094
		═════════	═════════

Provisions for liabilities

The amounts provided for deferred taxation are analysed below:

Capital

Total

Total

allowances

2024

2023

At financial year start

(3)

(3)

(9,654)

Charged to profit and loss

(11,047)

(11,047)

9,651

─────────

At financial year end

(11,050)

(3)

═════════

10.

Capital commitments

At the year ended 31 December 2023 Metro Bank plc has a fixed and floating charge against the assets of Eye-Docs Limited.

11.

Related party transactions

The company has availed of the exemption under FRS 102 Section 1A in relation to the disclosure of transactions with group undertakings.

12.

Parent and ultimate parent company

During the year, the immediate parent entity was Midland Eye Holdings Limited, a company incorporated in England and Wales.

The companys ultimate parent undertaking is Eye-Docs Holdings Limited.

The parent Companies address is 50 Lode Lane, Solihull, West Midlands, United Kingdom, B91 2AW

13.

Events After the End of the Reporting Period

There have been no significant events affecting the company since the financial year-end.